KeyCorp Boosts Corteva (NYSE:CTVA) Price Target to $71.00

Corteva (NYSE:CTVA - Get Free Report) had its price objective boosted by KeyCorp from $70.00 to $71.00 in a research report issued on Monday, MarketBeat.com reports. The firm presently has an "overweight" rating on the stock. KeyCorp's price target suggests a potential upside of 18.95% from the company's previous close. KeyCorp also issued estimates for Corteva's Q1 2025 earnings at $0.87 EPS, Q2 2025 earnings at $2.07 EPS, Q3 2025 earnings at ($0.27) EPS, Q4 2025 earnings at $0.37 EPS, FY2025 earnings at $3.03 EPS and FY2026 earnings at $3.47 EPS.

A number of other brokerages have also commented on CTVA. The Goldman Sachs Group assumed coverage on shares of Corteva in a report on Thursday, March 13th. They set a "buy" rating and a $71.00 price objective on the stock. BNP Paribas upgraded Corteva to a "hold" rating in a report on Monday, February 10th. Bank of America upped their price objective on Corteva from $69.00 to $73.00 and gave the stock a "buy" rating in a research report on Tuesday, February 11th. Wells Fargo & Company boosted their target price on Corteva from $67.00 to $73.00 and gave the company an "overweight" rating in a research note on Tuesday, January 28th. Finally, Royal Bank of Canada raised their price target on shares of Corteva from $72.00 to $73.00 and gave the stock an "outperform" rating in a research note on Friday, February 7th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and fourteen have assigned a buy rating to the company's stock. Based on data from MarketBeat, Corteva has a consensus rating of "Moderate Buy" and an average price target of $68.13.

Corteva Trading Up 0.8 %

Shares of NYSE:CTVA traded up $0.49 during mid-day trading on Monday, reaching $59.69. The stock had a trading volume of 3,661,138 shares, compared to its average volume of 3,314,795. Corteva has a twelve month low of $50.01 and a twelve month high of $66.24. The company has a current ratio of 1.45, a quick ratio of 0.93 and a debt-to-equity ratio of 0.08. The firm has a market cap of $40.77 billion, a PE ratio of 46.27, a price-to-earnings-growth ratio of 1.68 and a beta of 0.73. The firm has a 50 day simple moving average of $60.97 and a two-hundred day simple moving average of $60.28.

Corteva (NYSE:CTVA - Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The company reported $0.32 EPS for the quarter, missing analysts' consensus estimates of $0.34 by ($0.02). Corteva had a net margin of 5.36% and a return on equity of 7.19%. On average, research analysts predict that Corteva will post 2.96 EPS for the current fiscal year.

Insider Transactions at Corteva

In other Corteva news, insider Brian Titus sold 26,560 shares of Corteva stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $63.74, for a total value of $1,692,934.40. Following the completion of the sale, the insider now owns 11,347 shares in the company, valued at $723,257.78. The trade was a 70.07 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.14% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Corteva

Several institutional investors have recently made changes to their positions in CTVA. Vanguard Group Inc. increased its position in shares of Corteva by 0.8% in the fourth quarter. Vanguard Group Inc. now owns 79,174,847 shares of the company's stock worth $4,509,799,000 after purchasing an additional 646,459 shares during the period. Independent Franchise Partners LLP lifted its holdings in shares of Corteva by 51.5% during the 4th quarter. Independent Franchise Partners LLP now owns 16,496,508 shares of the company's stock worth $939,641,000 after acquiring an additional 5,604,838 shares during the period. Franklin Resources Inc. boosted its position in shares of Corteva by 9.2% during the 4th quarter. Franklin Resources Inc. now owns 16,143,025 shares of the company's stock worth $919,507,000 after acquiring an additional 1,354,418 shares in the last quarter. Capital World Investors raised its position in Corteva by 2,874.6% during the fourth quarter. Capital World Investors now owns 12,812,151 shares of the company's stock valued at $729,780,000 after purchasing an additional 12,381,436 shares in the last quarter. Finally, Northern Trust Corp boosted its stake in Corteva by 5.5% in the fourth quarter. Northern Trust Corp now owns 11,648,890 shares of the company's stock valued at $663,521,000 after buying an additional 608,898 shares in the last quarter. 81.54% of the stock is currently owned by institutional investors.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.